Thursday, Apr 23rd
Last update08:56:53 AM GMT
Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
 A Pennsylvania court on Monday said that the state’s constitution guarantees a right to abortion while... |
 Donald Trump has selected Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC),... | ||
 When Bug got home from school one winter afternoon in late 2024, his mother was on... |
 More than 3.1 million bottles of eye drops sold at major retailers, including Walgreens and CVS,... |
